203 related articles for article (PubMed ID: 18426080)
1. The association of MMP-1, -3 and -9 genotypes with the prognosis of HCV-related hepatocellular carcinoma patients.
Okamoto K; Mandai M; Mimura K; Murawaki Y; Yuasa I
Res Commun Mol Pathol Pharmacol; 2005; 117-118():77-89. PubMed ID: 18426080
[TBL] [Abstract][Full Text] [Related]
2. Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease.
Okamoto K; Mimura K; Murawaki Y; Yuasa I
J Gastroenterol Hepatol; 2005 Jul; 20(7):1102-8. PubMed ID: 15955221
[TBL] [Abstract][Full Text] [Related]
3. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y
Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-1, -3, and -9 gene polymorphisms and the risk of idiopathic dilated cardiomyopathy in a Chinese Han population.
Tang LJ; Chen XF; Zhu M; Jiang JJ; Lu XB; Du YX; Wang B; Fang CF; Xue YS; Shen WF
Clin Biochem; 2007 Dec; 40(18):1427-30. PubMed ID: 18028894
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas.
Nasr HB; Mestiri S; Chahed K; Bouaouina N; Gabbouj S; Jalbout M; Chouchane L
Clin Chim Acta; 2007 Sep; 384(1-2):57-63. PubMed ID: 17599818
[TBL] [Abstract][Full Text] [Related]
6. The genotypes of IL-1 beta and MMP-3 are associated with the prognosis of HCV-related hepatocellular carcinoma.
Okamoto K; Ishida C; Ikebuchi Y; Mandai M; Mimura K; Murawaki Y; Yuasa I
Intern Med; 2010; 49(10):887-95. PubMed ID: 20467172
[TBL] [Abstract][Full Text] [Related]
7. [Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis].
Kang S; Wang Y; Zhang JH; Jin X; Fang SM; Li Y
Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):601-4. PubMed ID: 16202315
[TBL] [Abstract][Full Text] [Related]
8. [Association of single nucleotide polymorphism in matrix metalloproteinases promoter with susceptibility to ovarian cancer].
Li Y; Wang Y; Kang S; Zhang JH; Guo W; Wang N; Jin X; Fang SM
Zhonghua Fu Chan Ke Za Zhi; 2005 Jul; 40(7):472-5. PubMed ID: 16080875
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.
Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J
Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613
[TBL] [Abstract][Full Text] [Related]
10. Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users.
Tu HF; Wu CH; Kao SY; Liu CJ; Liu TY; Lui MT
J Oral Pathol Med; 2007 Aug; 36(7):409-14. PubMed ID: 17617834
[TBL] [Abstract][Full Text] [Related]
11. No association of MMP-7, MMP-8, and MMP-21 polymorphisms with the risk of hepatocellular carcinoma in a Chinese population.
Qiu W; Zhou G; Zhai Y; Zhang X; Xie W; Zhang H; Yang H; Zhi L; Yuan X; Zhang X; He F
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2514-8. PubMed ID: 18768525
[TBL] [Abstract][Full Text] [Related]
12. Association of matrix metalloproteinase (MMP)-1 promoter polymorphism with head and neck squamous cell carcinoma.
Hashimoto T; Uchida K; Okayama N; Imate Y; Suehiro Y; Hamanaka Y; Ueyama Y; Shinozaki F; Yamashita H; Hinoda Y
Cancer Lett; 2004 Jul; 211(1):19-24. PubMed ID: 15194213
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer.
Zinzindohoué F; Lecomte T; Ferraz JM; Houllier AM; Cugnenc PH; Berger A; Blons H; Laurent-Puig P
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):594-9. PubMed ID: 15701845
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms in the MMP-1 and MMP-3 gene may contribute to chronic periodontitis in a Brazilian population.
Astolfi CM; Shinohara AL; da Silva RA; Santos MC; Line SR; de Souza AP
J Clin Periodontol; 2006 Oct; 33(10):699-703. PubMed ID: 16899023
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-1 and -9 promoter polymorphisms are not associated with an increased risk of uterine leiomyomas in a Japanese population.
Takemura N; Yoshida S; Kennedy S; Deguchi M; Ohara N; Maruo T
J Soc Gynecol Investig; 2006 Apr; 13(3):232-6. PubMed ID: 16638593
[TBL] [Abstract][Full Text] [Related]
16. Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer.
Su L; Zhou W; Asomaning K; Lin X; Wain JC; Lynch TJ; Liu G; Christiani DC
Carcinogenesis; 2006 May; 27(5):1024-9. PubMed ID: 16311244
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer.
Woo M; Park K; Nam J; Kim JC
J Gastroenterol Hepatol; 2007 Jul; 22(7):1064-70. PubMed ID: 17608852
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion.
Pereza N; Ostojić S; Volk M; Kapović M; Peterlin B
Reprod Biomed Online; 2012 May; 24(5):567-75. PubMed ID: 22406112
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype.
Grieu F; Li WQ; Iacopetta B
Breast Cancer Res Treat; 2004 Dec; 88(3):197-204. PubMed ID: 15609121
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with mortality in haemodialysis patients.
Cozzolino M; Biondi ML; Galassi A; Turri O; Brancaccio D; Gallieni M
Nephrol Dial Transplant; 2009 Jul; 24(7):2207-12. PubMed ID: 19221176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
